Kelsey LS - Search Results

1

Hematopoietic augmentation by a beta-(1,4)-linked mannan.

Egger SF, Brown GS, Kelsey LS, Yates KM, Rosenberg LJ, Talmadge JE. Egger SF, et al. Among authors: kelsey ls. Cancer Immunol Immunother. 1996 Dec;43(4):195-205. doi: 10.1007/s002620050322. Cancer Immunol Immunother. 1996. PMID: 9003464

2

Interleukin-12 enhances peripheral hematopoiesis in vivo.

Jackson JD, Yan Y, Brunda MJ, Kelsey LS, Talmadge JE. Jackson JD, et al. Among authors: kelsey ls. Blood. 1995 May 1;85(9):2371-6. Blood. 1995. PMID: 7727771 Free article.

3

In vivo protective effects of tetrapeptide AcSDKP, with or without granulocyte colony-stimulation factor, on murine progenitor cells after sublethal irradiation.

Watanabe T, Brown GS, Kelsey LS, Yan Y, Jackson JD, Ewel C, Kessinger A, Talmadge JE. Watanabe T, et al. Among authors: kelsey ls. Exp Hematol. 1996 May;24(6):713-21. Exp Hematol. 1996. PMID: 8635527

4

Studies on optimal dose and administration schedule of a hematopoietic stimulatory beta-(1,4)-linked mannan.

Egger SF, Brown GS, Kelsey LS, Yates KM, Rosenberg LJ, Talmadge JE. Egger SF, et al. Among authors: kelsey ls. Int J Immunopharmacol. 1996 Feb;18(2):113-26. doi: 10.1016/0192-0561(95)00112-3. Int J Immunopharmacol. 1996. PMID: 8799361

5

In vivo haemoprotective activity of tetrapeptide AcSDKP combined with granulocyte-colony stimulating factor following sublethal irradiation.

Watanabe T, Kelsey LS, Yan Y, Brown GS, Jackson JD, Ewel C, Talmadge JE. Watanabe T, et al. Among authors: kelsey ls. Br J Haematol. 1996 Sep;94(4):619-27. doi: 10.1046/j.1365-2141.1996.d01-1853.x. Br J Haematol. 1996. PMID: 8826883

6

T-cell reconstitution by molecular, phenotypic, and functional analysis in the thymus, bone marrow, spleen, and blood following split-dose polychemotherapy and therapeutic activity for metastatic breast cancer in mice.

Talmadge JE, Jackson JD, Kelsey L, Borgeson CD, Faltynek C, Perry GA. Talmadge JE, et al. J Immunother Emphasis Tumor Immunol. 1993 Nov;14(4):258-68. doi: 10.1097/00002371-199311000-00002. J Immunother Emphasis Tumor Immunol. 1993. PMID: 7506577

7

Anti-inflammatory activity of an orally active peptide sequence from PF-4 on acute inflammation and DTH.

Talmadge JE, Kelsey LS, Brown GS, Counts DF. Talmadge JE, et al. Among authors: kelsey ls. Inflamm Res. 1995 Aug;44 Suppl 2:S199-200. doi: 10.1007/BF01778331. Inflamm Res. 1995. PMID: 8548397 No abstract available.

8

Adenovirus p53 purging for human breast cancer stem cell products.

Hirai M, Kelsey LS, Maneval DC, Vaillancourt M, Talmadge JE. Hirai M, et al. Among authors: kelsey ls. Acta Haematol. 1999;101(2):97-105. doi: 10.1159/000040931. Acta Haematol. 1999. PMID: 10202240

9

Purging of human breast cancer cells from stem cell products with an adenovirus containing p53.

Hirai M, Kelsey LS, Vaillancourt M, Maneval DC, Watanabe T, Talmadge JE. Hirai M, et al. Among authors: kelsey ls. Cancer Gene Ther. 2000 Feb;7(2):197-206. doi: 10.1038/sj.cgt.7700088. Cancer Gene Ther. 2000. PMID: 10770627

10

Enhancement of adenovirus-mediated gene transfer to human bone marrow cells.

Watanabe T, Kelsey L, Ageitos A, Kuszynski C, Ino K, Heimann DG, Varney MT, Shepard HM, Vaillancourt MT, Maneval DC, Talmadge JE. Watanabe T, et al. Leuk Lymphoma. 1998 May;29(5-6):439-51. doi: 10.3109/10428199809050904. Leuk Lymphoma. 1998. PMID: 9643558

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21 results

Search Page